These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 471867)

  • 41. Epsilon-Aminocaproic Acid Has No Association With Thromboembolic Complications, Renal Failure, or Mortality After Liver Transplantation.
    Nicolau-Raducu R; Ku TC; Ganier DR; Evans BM; Koveleskie J; Daly WJ; Fish B; Cohen AJ; Reichman TW; Bohorquez HE; Bruce DS; Carmody IC; Loss GE; Gitman M; Marshall T; Nossaman BD
    J Cardiothorac Vasc Anesth; 2016 Aug; 30(4):917-23. PubMed ID: 27020101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safe and effective, prolonged administration of epsilon aminocaproic acid in bleeding from the urinary tract.
    Stefanini M; English HA; Taylor AE
    J Urol; 1990 Mar; 143(3):559-61. PubMed ID: 2304169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EPSILON-AMINOCAPROIC ACID (EACA).
    NAHUM LH
    Conn Med; 1964 Sep; 28():641-5. PubMed ID: 14201313
    [No Abstract]   [Full Text] [Related]  

  • 44. [THE EFFECT OF EPSILON-AMINOCAPROIC ACID (EACA) ON BLOOD COAGULATION TIME].
    GAERTNER H; LISIEWICZ J; SIEROSLAWSKI H; SZIRMAI E
    Acta Med Okayama (1952); 1963 Jun; 17():123-6. PubMed ID: 14121937
    [No Abstract]   [Full Text] [Related]  

  • 45. [THE EFFECT OF EPSILON-AMINOCAPROIC (EACA) ON PLASMA COAGULATION TIME].
    GAERTNER HA; LISIEWICZ J; SIEROSLAWSKI H; SZIRMAI E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1963; 80():463-7. PubMed ID: 14123772
    [No Abstract]   [Full Text] [Related]  

  • 46. Haemorrhagic cystitis treated with epsilon-aminocaproic acid.
    Aroney RS; Dalley DN; Levi JA
    Med J Aust; 1980 Jul; 2(2):92. PubMed ID: 7421660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spontaneous subarachnoid hemorrhage complicated by communicating hydrocephalus: epsilon amino caproic acid as a possible predisposing factor.
    Park BE
    Surg Neurol; 1979 Jan; 11(1):73-80. PubMed ID: 451853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epsilon-aminocaproic acid and recurrent subarachnoid hemorrhage: a clinical trial.
    Shucart WA; Hussain SK; Cooper PR
    J Neurosurg; 1980 Jul; 53(1):28-31. PubMed ID: 7411206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sarcoid myopathy with elevated creatine phosphokinase.
    Ando DG; Lynch JP; Fantone JC
    Am Rev Respir Dis; 1985 Feb; 131(2):298-300. PubMed ID: 3970459
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stabilizing effect of epsilon-aminocaproic acid on allergenic extracts.
    Van Hoeyveld EM; Stevens EA
    J Allergy Clin Immunol; 1985 Oct; 76(4):543-50. PubMed ID: 4056242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. METHOD FOR DETERMINING EPSILON-AMINOCAPROIC ACID (EACA) IN BLOOD PLASMA, BASED ON THE ANTIFIBRINOLYTIC PROPERTIES OF THIS COMPOUND.
    WOLOSOWICZ N; NIEWIAROWSKI S; CZEREPKO K
    Thromb Diath Haemorrh; 1964 Jan; 10():309-16. PubMed ID: 14113373
    [No Abstract]   [Full Text] [Related]  

  • 52. The effects of epsilon aminocaproic acid on contractile properties and catecholamine content of rat carotid arteries.
    Barry KJ; Selland BA; Stein BM
    Surg Neurol; 1982 Apr; 17(4):273-8. PubMed ID: 7079951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Scleromyxedema myopathy: case report and review of the literature.
    Helfrich DJ; Walker ER; Martinez AJ; Medsger TA
    Arthritis Rheum; 1988 Nov; 31(11):1437-41. PubMed ID: 3056423
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Control of bleeding after renal biopsy with epsilon-amino-caproic acid.
    Savdie E; Mahony JF; Storey BG
    Br J Urol; 1978 Feb; 50(1):8-11. PubMed ID: 630206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibtion of cold insolubility of serum cryoglobulin by epsilon aminocaproic acid.
    Lalezari P; Kumar M
    Am J Med; 1980 Apr; 68(4):629-32. PubMed ID: 7369238
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A NEW METHOD OF THE ANALYSIS OF EPSILON-AMINOCAPROIC ACID (EACA) AND AMINOMETHYLCYCLOHEXANE CARBOXYLIC ACID (AMCHA), THE POTENT ANTIFIBRINOLYTIC AGENTS].
    TAKATA Y; TAKATA A; OKAMOTO U
    Nihon Seirigaku Zasshi; 1964 May; 26():281-5. PubMed ID: 14172890
    [No Abstract]   [Full Text] [Related]  

  • 57. Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients.
    Casado E; Gratacós J; Tolosa C; Martínez JM; Ojanguren I; Ariza A; Real J; Sanjuán A; Larrosa M
    Ann Rheum Dis; 2006 Mar; 65(3):385-90. PubMed ID: 16096334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [FATE OF ANTIBODIES DURING THE COURSE OF SPONTANEOUS CLEAVAGE OF PLACENTAL GAMMA GLOBULIN AND THE INHIBITORY EFFECT OF EPSILON-AMINOCAPROIC ACID (EACA)].
    SKVARIL F; GRUENBERGER D; DREVO M; SLONIM D; STRAUSS J
    Cesk Epidemiol Mikrobiol Imunol; 1964 Nov; 13():343-50. PubMed ID: 14245903
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of epsilon aminocaproic acid and tranexamic Acid in thoracic aortic surgery: clinical efficacy and safety.
    Makhija N; Sarupria A; Kumar Choudhary S; Das S; Lakshmy R; Kiran U
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1201-7. PubMed ID: 24050855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute hyperkalemia associated with intravenous epsilon-aminocaproic acid therapy.
    Perazella MA; Biswas P
    Am J Kidney Dis; 1999 Apr; 33(4):782-5. PubMed ID: 10196024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.